Green Thumb Industries (GTBIF) Total Debt Growth (1y) (2020 - 2026)
Green Thumb Industries (GTBIF) Total Debt Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 41.53% |
| 10 | Green Thumb Industries | 1.66 Bn | 1.37 Bn | 137.87 Mn | 13.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.23% |
| Mar 31, 2026 | 86.91% |
| Dec 31, 2025 | -11.20% |
| Sep 30, 2025 | -9.94% |
| Jun 30, 2025 | 203.05% |
| Mar 31, 2025 | -53.57% |
| Dec 31, 2024 | -16.55% |
| Sep 30, 2024 | -13.97% |
| Jun 30, 2024 | -71.45% |
| Mar 31, 2024 | 6.50% |
| Dec 31, 2023 | 6.82% |
| Sep 30, 2023 | 11.42% |
| Jun 30, 2023 | 9.67% |
| Mar 31, 2023 | 9.19% |
| Dec 31, 2022 | -1.18% |
| Sep 30, 2022 | -2.66% |
| Jun 30, 2022 | 27.27% |
| Mar 31, 2022 | 140.75% |
| Dec 31, 2021 | 139.47% |
| Sep 30, 2021 | 120.61% |